Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09WYL
|
||||
Former ID |
DIB010428
|
||||
Drug Name |
GSK-557296
|
||||
Synonyms |
Epelsiban; Epelsiban besylate; Premature ejaculation therapeutic (oral), GlaxoSmithKline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Premature ejaculation [ICD9: 302.75; ICD10:F52.4] | Phase 2 | [522869] | ||
Company |
GlaxoSmithKline plc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C30H38N4O4
|
||||
Canonical SMILES |
C1CN(CCO1)C(=O)[C@H](N1[C@@H](C(=O)N[C@@H](C1=O)C1Cc2c(<br />C1)cccc2)[C@@H](C)CC)c1c(nc(cc1)C)C
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Oxytocin receptor | Target Info | Antagonist | [532286] | |
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
PANTHER Pathway | Oxytocin receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.